Advertisement
New Zealand markets open in 9 hours 22 minutes
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5950
    +0.0013 (+0.21%)
     
  • NZD/EUR

    0.5550
    +0.0004 (+0.08%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    83.27
    +0.46 (+0.56%)
     
  • GOLD

    2,338.60
    +0.20 (+0.01%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,101.41
    +61.03 (+0.76%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,998.18
    -90.52 (-0.50%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.4220
    +0.3070 (+0.33%)
     

Bristol-Myers Squibb’s Oncology Treatment Growth Drivers

Bristol-Myers Squibb’s Oncology Treatment Growth Drivers

Revenue for Bristol-Myers Squibb's (BMY) Opdivo has grown by a double-digit percentage YoY (year-over-year) since 2016.